Institutionelle bei Idec Pharmaceuticals

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Citigroup Inc. 15,183,879 $538,268,510
Morgan Stanley 7,994,755 $283,414,064
BB Biotech Ag 4,682,000 $165,976,900
Putnam Investment Management, Inc. 4,370,071 $154,919,016
American Express Financial Corp 4,268,698 $151,325,344
Oppenheimerfunds, Inc. 4,048,265 $143,510,994
FMR Corporation (Fidelity Management & Research Corp) 18,819,494 $667,151,062
Allianz Dresdner Asset Management Of America, Inc. 3,003,298 $106,466,914
Barclays Bank Plc 2,831,648 $100,381,921
Price (T.Rowe) Associates 2,795,204 $99,089,981

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 4,800,000 $170,160,000
Fidelity Aggressive Growth Fund 4,717,250 $167,226,512
Fidelity Select Portfolios - Biotechnology 3,371,140 $119,506,913
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 3,192,680 $113,180,506
Fidelity Otc Portfolio 1,570,000 $55,656,500
Growth Fund of America Inc 1,558,500 $55,248,825
Vanguard Specialized-Health Care Fund 1,560,000 $55,302,000
Morgan Stanley American Opportunities Fd 1,389,410 $49,254,584
Fidelity Mid-Cap Stock Fund 1,383,420 $49,042,239
Merrill Lynch Fundamental Growth Fund 1,320,000 $46,794,000